Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huestis & Smith Toxicology is a private U.S. toxicology consulting company focused on clinical and forensic toxicology rather than therapeutic drug development. The firm appears to be led by noted toxicologist Dr. Marilyn A. Huestis, with Michael L. Smith also associated with the business, and is active as an LLC in Maryland and Virginia. Its work is centered on expert consulting and scientific advisory services in areas such as cannabinoid pharmacology and toxicology, oral fluid drug testing, driving under the influence of drugs, prenatal drug exposure, novel psychoactive substances, and related analytical and regulatory questions. Based on available public information, the company does not appear to have a disclosed therapeutic pipeline, platform, or proprietary drug assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huestis & Smith Toxicology.